Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Dapagliflozin impurity A

Dapagliflozin impurity A (Compound A) is a dapagliflozin peroxide, a genotoxic impurity, can cause damage to human genetic material at very low concentrations, leading to genetic mutations and possibly tumorigenesis[1].

Product Specifications

CAS Number

[2452300-94-4]

UNSPSC

12352005

Target

Drug Derivative

Type

Reference compound

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/dapagliflozin-impurity-a.html

Solubility

10 mM in DMSO

Smiles

O[C@H]1[C@H](C2=CC(C(C3=CC=C(C=C3)OCC)OO)=C(C=C2)Cl)O[C@@H]([C@H]([C@@H]1O)O)CO

Molecular Formula

C21H25ClO8

Molecular Weight

440.87

References & Citations

[1]Cao Jing, et al. Preparation of dapagliflozin peroxide. China, CN116410163 A. 2023-07-11.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

UGT3A2 AAV Vector (Human) (CMV)
49148101 1 µg

UGT3A2 AAV Vector (Human) (CMV)

Sign In for Pricing
View Details
Recombinant Bordetella Parapertussis glmU Protein (aa 1-457)
VAng-Lsx4625-1mgEcoli 1 mg (E. coli)

Recombinant Bordetella Parapertussis glmU Protein (aa 1-457)

Sign In for Pricing
View Details
RSPH3 Antibody
A59459-100UG 100 µg

RSPH3 Antibody

Sign In for Pricing
View Details
Anti-ADRA1A Rabbit Monoclonal Antibody
B2020923 100 µL

Anti-ADRA1A Rabbit Monoclonal Antibody

Sign In for Pricing
View Details
NOL5A (NOP56) (NM_006392) Human Over-expression Lysate
LS010528-20ug 20 µg

NOL5A (NOP56) (NM_006392) Human Over-expression Lysate

Sign In for Pricing
View Details
NALCN sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
K1387708 1.0 µg DNA

NALCN sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

Sign In for Pricing
View Details